Investors / Ireland / Fountain Healthcare Partners
Fountain Healthcare Partners
Venture capital · Dublin, Ireland · Europe
Fountain Healthcare Partners is a venture fund that provides risk capital and expertise to entrepreneurs building life sciences companies. It leads or co-leads investment syndicates and has offices in Dublin and New York.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiopharmaceuticalsmedical devicesdiagnosticsspecialty pharmahealthcare
Your fit with Fountain Healthcare Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsFountain Healthcare Partners lists 13 checked portfolio companies on its own site and is named in 3 funding rounds. Its most frequent entry is Series A, 33% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 43% of its companies are based in United States. It invests most often alongside HealthCap, Jeito Capital and LifeArc Ventures.
Counts come from funding rounds that name Fountain Healthcare Partners, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Fountain Healthcare Partners' whole history. Rounds on record name 3 companies; its own site lists 13. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 33% |
| Series B | 33% |
| Growth | 33% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 3 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 33th | 13 companies |
| Recent activity | 77th | 3 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 94th | 23% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 69th | 4 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| HealthCap | 2 |
| Jeito Capital | 2 |
| LifeArc Ventures | 2 |
| ARTIS | 1 |
| Altamont Pharmaceutical Holdings | 1 |
| Angelini Ventures | 1 |
| Atlantic Bridge | 1 |
| Avoro Capital Advisors | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers1292%
- No longer answers00%
- Points to another company18%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Fountain Healthcare Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Fountain Healthcare Partners| Date | Company | Stage |
|---|---|---|
| 14 Oct 2026 | Series A | |
| 11 Feb 2026 | Series C+ | |
| 20 Jan 2026 | Series B |
Round details for Fountain Healthcare Partners
Amounts, full round histories and every co-investor in Fountain Healthcare Partners' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
13 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
| Altay Therapeutics develops small molecules to address serious diseases by inhibiting transcription factors | Healthcare & Biotech | Oct 2026Series A | Page + round | |
| Amarin is a global pharmaceutical company that has developed and is pursuing additional treatments to help address cardiovascular disease. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Corteria Pharmaceuticals is a privately held company developing first-in-class drugs for indications of high unmet medical need, such as obesity, heart failure subpopulations and autosomal dominant polycystic kidney disease | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Exciva is developing a groundbreaking therapy that effectively and safely addresses neuropsychiatric symptoms including agitation in patients with Alzheimer’s disease dementia. | Healthcare & Biotech | Jan 2026Series B | Page + round | |
| The company develops and provides robotic microsurgery systems and instruments for surgeons to perform complex procedures with greater precision and control. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Feb 2026Series C+ | Page + round | ||
| Neuromod develops a tinnitus treatment device called Lenire | Healthcare & Biotech | Portfolio page | ||
| Priothera develops innovative immune modulators for the treatment of hematological malignancies | Healthcare & Biotech | Portfolio page | ||
| Vivasure Medical develops a vascular closure system for arterial and venous access. | Healthcare & Biotech | Portfolio page | ||
| XyloCor Therapeutics is focused on improving the lives of patients through our commitment to advancing novel therapies for coronary artery disease. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- fh-partners.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 20 Jan 2026
- Companies checked
- 13
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Fountain Healthcare Partners' profile as data
Pull Fountain Healthcare Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/fh-partners.com
# also
GET /v1/firms/fh-partners.com/portfolio
GET /v1/firms/fh-partners.com/coinvestors
GET /v1/firms/fh-partners.com/news